Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith a copy of the Annual Report of the Company for the financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mardia Samyoung Capillary Tubes Company has submitted its 33rd Annual Report for the financial year ended 31st March 2025, along with the notice for the AGM scheduled on 21st September 2025 via video conferencing. The company swung to a net profit of Rs. 1.20 crore in FY25, compared to a loss of Rs. 50.98 lakh in the previous year. There were no interest, financial charges, or depreciation during the year, and no dividend has been recommended. The board saw significant churn, with several directors retiring on 26 June 2025 and new directors (including two Independent Directors and a Non-Executive Director) being appointed. Shareholders will also vote on appointing SCS & CO. LLP as Secretarial Auditors for five years and on shifting the registered office from Maharashtra to Gujarat.
The sharp swing from loss to profit is a positive signal for shareholders, though the no-dividend decision and operational dependence on zero depreciation/interest figures warrant closer scrutiny. The board reshuffle and proposed office relocation to Gujarat are administrative changes with no immediate financial impact.